Merck arthritis drug has fewer side-effects
230804
A new arthritis drug made by Merck & Co. causes fewer stomach disorders and complications than an older painkiller, researchers said on Friday.
208543
Vioxx was already a big success as an arthritis pain reliever, but Merck &amp; Co. thought it could be an even bigger seller. The drug seemed to have some cancer-prevention qualities
583563
a widely prescribed arthritis treatment - more than doubled patients&#39; risk of heart problems in a clinical study. The announcement, 11 weeks after Merck &amp; Co.
421836
Merck & Co.  on Friday said U.S. regulators have decided not to approve the company's experimental arthritis drug, the successor to its recalled Vioxx pill, until more safety and effectiveness data are obtained.
452190
A new HIV-fighting drug from Merck &amp; Co. appears superior to options for patients who have stopped responding to available drugs, federal regulators said Friday.
291930
Drug firm Merck &amp; Co. will present data this week showing that an experimental arthritis drug, Arcoxia, a treatment in the same class as its recently withdrawn Vioxx, showed no significant
316374
Merck &amp; Co&#39;s decision to stop selling the painkiller Vioxx, one of its most profitable drugs, could hardly have come at a worse time for the company.
130636
The furor over the safety of arthritis painkilling medications shows no sign of abating. Vioxx is gone from the market, following data linking it to increased cardiovascular risk.
667
The Food and Drug Administration insists that until pharmaceutical giant Merck presented new information this week, there was not enough evidence to pull the arthritis drug Vioxx off the market.
202073
Americans should feel reasonably safe taking government-approved prescription drugs &#151; with a few caveats &#151; even after a popular arthritis medication was pulled from the market, medical experts say. But the problems with Vioxx raise questions about the Food and Drug Administration's safety review process and the length of time it took Merck to pull the drug, observers say.
125021
Merck & Co. MRK.N on Friday said  U.S. regulators have decided not to approve the company's  experimental arthritis drug, the successor to its recalled  Vioxx pill, until more safety and effectiveness data are  obtained.
289198
Novartis' pain killer Prexige did not raise the rate of serious heart problems and led to fewer ulcer problems compared to normal anti-inflammatory drugs, results of a study of over 18,000 patients showed.
526650
The painkiller Celebrex is so effective in treating arthritis that doctors will probably continue to prescribe it, despite a new study that shows that, at high doses, it increases the risk of heart attacks.
534607
Drug maker Merck & Co. Inc. said on  Friday it acted "responsibly and appropriately" in developing  and marketing recently recalled arthritis drug Vioxx.
754465
By E.J. Mundell, HealthDay Reporter    Other drugs on the market offer arthritis relief, experts say    HealthDayNews -- A day after one of the largest drug recalls in history, America's 2 million Vioxx users are left wondering what's next in terms of relieving their arthritis pain...
574550
GAITHERSBURG, Md.  - The heart attack and stroke  risks linked to withdrawn arthritis drug Vioxx are an inherent  problem for similar pain pills, Vioxx maker Merck & Co. Inc.  MRK.N told advisers to the U.S. Food and Drug Administration  on Wednesday.
467982
&#151; Merck & Co., the US drug maker that recalled its Vioxx painkiller because of a link to heart disease, said short-term studies show the company's planned successor pill, Arcoxia, is safer.